U.S. FDA approves first mRNA flu shot from Moderna

Only right-leaning outlets are covering this.

How each outlet headlined it

• CNBC left

  U.S. FDA approves first mRNA flu shot from Moderna
• STAT News center

  In today's Pharmalittle newsletter: Moderna's mRNA flu shot approved, a death reported in a gene-editing trial in China, and more.
• The Guardian left

  The mFlusiva vaccine for older people is the first made with the mRNA platform key to ending the coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic, Moderna, the manufacturer, said. The shot, named mFlusiva, is intended for adults aged 50 or older. Other brands of flu shots already have begun arriving in pharmacies ahead of fall vaccination season,